Javascript must be enabled to continue!
Initial treatment for patients with temporomandibular disorders: pain relief and muscle tone relief by photobiomodulation therapy using carbon dioxide laser
View through CrossRef
Abstract
Purpose
To investigate the efficacy of photobiomodulation therapy (PBMT) with a CO2 laser (Bel Laser, Takara Belmont, CO. Ltd., Osaka, Japan; wavelength 10.6 μm) (tissue surface absorption effects) in conjunction with mouth opening training in patients with temporomandibular disorders (TMDs).
Methods
This is a retrospective study on TMD patients with pre- and post-treatment assessments. The study included 36 patients (7 men and 29 women, mean age 58.2 years (SD 18.3)) (after excluding 4 patients due to dropouts, loss to follow up or refusal of treatment) with symptoms of pain and muscle tenderness during mouth opening. Treatment included Amfenac sodium (50 mg per day, thrice daily after meals) for 1–2 weeks for acute symptoms. Based on the diagnostic criteria for TMD, we identified the trigger point (muscle contracture site). We implemented muscle massage and stretching therapy as mouth opening training after PBMT. The laser irradiance conditions were as follows: output 1.5 W, on time 0.01 s, off time 0.05 s, and repeat pulse. Distance between the laser source and the skin was approximately 10 cm; irradiation time was 3 min (approximately 56.9 J/cm2). Mouth opening training involved massaging the areas of muscle contracture that were the trigger points, as well as muscle stretching to improve temporomandibular joint flexibility. One PBMT cycle and mouth opening training was conducted per week for four cycles. We determined the effects before and after intervention. A numeric rating scale (NRS; range 0–10) was used to evaluate pain, and maximum mouth opening (MMO) capacity was also assessed. Data were analyzed using the Wilcoxon signed-rank test.
Results
The mean (SD) pain levels, as determined via NRS, were 4.9(3.6) and 2.7 (3.0) (p < 0.001), before and after four treatment cycles, respectively. The mean (SD) of MMO was 39.6 (5.9) and 44.6 mm (4.8) (p < 0.001), before and after treatment, respectively.
Conclusion
The current study suggests that PBMT using a CO2 laser combined with mouth opening training is effective for the treatment of temporomandibular disorders.
Springer Science and Business Media LLC
Title: Initial treatment for patients with temporomandibular disorders: pain relief and muscle tone relief by photobiomodulation therapy using carbon dioxide laser
Description:
Abstract
Purpose
To investigate the efficacy of photobiomodulation therapy (PBMT) with a CO2 laser (Bel Laser, Takara Belmont, CO.
Ltd.
, Osaka, Japan; wavelength 10.
6 μm) (tissue surface absorption effects) in conjunction with mouth opening training in patients with temporomandibular disorders (TMDs).
Methods
This is a retrospective study on TMD patients with pre- and post-treatment assessments.
The study included 36 patients (7 men and 29 women, mean age 58.
2 years (SD 18.
3)) (after excluding 4 patients due to dropouts, loss to follow up or refusal of treatment) with symptoms of pain and muscle tenderness during mouth opening.
Treatment included Amfenac sodium (50 mg per day, thrice daily after meals) for 1–2 weeks for acute symptoms.
Based on the diagnostic criteria for TMD, we identified the trigger point (muscle contracture site).
We implemented muscle massage and stretching therapy as mouth opening training after PBMT.
The laser irradiance conditions were as follows: output 1.
5 W, on time 0.
01 s, off time 0.
05 s, and repeat pulse.
Distance between the laser source and the skin was approximately 10 cm; irradiation time was 3 min (approximately 56.
9 J/cm2).
Mouth opening training involved massaging the areas of muscle contracture that were the trigger points, as well as muscle stretching to improve temporomandibular joint flexibility.
One PBMT cycle and mouth opening training was conducted per week for four cycles.
We determined the effects before and after intervention.
A numeric rating scale (NRS; range 0–10) was used to evaluate pain, and maximum mouth opening (MMO) capacity was also assessed.
Data were analyzed using the Wilcoxon signed-rank test.
Results
The mean (SD) pain levels, as determined via NRS, were 4.
9(3.
6) and 2.
7 (3.
0) (p < 0.
001), before and after four treatment cycles, respectively.
The mean (SD) of MMO was 39.
6 (5.
9) and 44.
6 mm (4.
8) (p < 0.
001), before and after treatment, respectively.
Conclusion
The current study suggests that PBMT using a CO2 laser combined with mouth opening training is effective for the treatment of temporomandibular disorders.
Related Results
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives:
Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abordagem terapêutica nas desordens temporomandibulares: técnicas de fisioterapia associadas ao tratamento odontológico
Abordagem terapêutica nas desordens temporomandibulares: técnicas de fisioterapia associadas ao tratamento odontológico
Responsáveis por amplo e variado quadro de sinais e sintomas de difícil diagnóstico, as desordens da articulação temporomandibular exigem tratamento complexo e multifatorial, já qu...
Subliminal emotional pictures are capable to modulate early cerebral responses to pain in fibromyalgia v1
Subliminal emotional pictures are capable to modulate early cerebral responses to pain in fibromyalgia v1
Participants A total of fifty-six right-handed women (29 healthy control (HC) subjects and 27 FM patients) took part in the experiment. All participants were aged between 33 and 63...
Temporomandibular Disorders: Current Diagnosis and Treatment Methods
Temporomandibular Disorders: Current Diagnosis and Treatment Methods
The term temporomandibular disorders is used as a collective term for a group of musculoskeletal disorders that involve pain dysfunction in the masticatory muscles, temporomandibul...

